Defy Medical’s store lists a premixed NAD+ injection and identifies a dispensing pharmacy for the particular product we reviewed. This is useful information for someone comparing pharmacy-specific prescriptions, but it is not a complete picture of the consultation, medication, supplies, and follow-up costs for a new patient.
We reviewed the public product listing on September 19, 2026. We did not open a patient account or place an order. One significant finding is that the instruction area contains generic material and references another medication, so it should not be used as a stand-alone guide for injecting NAD+.
Defy publishes a specific NAD+ product and pharmacy, but a complete care quote and corrected, prescription-specific instructions are essential before use.
What the product listing actually identifies
The Defy Medical store page describes a premixed 10 mL vial at 100 mg/mL and names BoomRX in its pharmacy field. These details identify the catalog entry we examined. They do not establish that every Defy NAD+ prescription uses the same pharmacy, concentration, or quantity.
Ask whether this is the preparation your clinician intends to prescribe and whether it is currently available in your state. If a different product is selected, request its own label and pharmacy details. A supplier field is a useful starting point for verification, not a reason to assume that different listings are interchangeable.
Obtain a complete new-patient quote
We did not establish an all-in public price from this product page. That leaves several separate questions: the initial consultation charge, whether testing is needed, the medication cost, supplies, shipping, and the terms of later follow-up. A number found in an older forum post cannot fill those gaps reliably.
Have the service separate one-time expenses from costs that recur. If you are already a patient, ask which existing services carry over to an NAD+ discussion and which require additional payment. The pricing guide helps organize that comparison without pretending that a vial price describes an entire course of care.
The instruction area needs direct clarification
The page’s generic injection information includes an HCG reference and confusing syringe-marking language. That is a concrete reason to ask the clinician and pharmacist for corrected directions tied to the NAD+ prescription and the exact equipment being supplied. We are not reproducing those generic instructions as a safe method to follow.
Request a demonstration and repeat the instructions back to the clinician if anything is unclear. The label and dosing questions guide explains the difference between a drug amount, a liquid volume, and a syringe marking. A review website cannot resolve an ambiguous prescription by guessing which part of a store page was intended.
Separate condition claims from product evidence
The store description mentions several mental-health and age-related concerns. Listing a condition in marketing copy does not demonstrate that this compounded formulation effectively treats it. Ask the prescriber to explain the evidence for your specific concern and whether the proposed approach complements or conflicts with established care you already receive.
The evidence review distinguishes studies of NAD metabolism from trials of a finished home-injection product. Do not interpret the presence of an NAD+ catalog item as a reason to change another prescribed treatment. A familiar medical brand and a detailed product description do not remove the need for an individualized assessment.
Who answers questions after dispensing?
For a pharmacy-specific order, identify the point of contact for medication quality, storage, and labeling concerns as well as the clinician responsible for medical follow-up. These responsibilities may sit with different organizations. Ask how a question is transferred between them so you are not left repeating the same issue to several support teams.
Discuss what happens if the supplied vial or syringe differs from the order description. Keep the order record and accompanying label, and have any mismatch resolved before use. The pharmacy verification guide can help you check the actual facility rather than relying solely on a storefront’s name.
Where Defy fits in the directory
Defy belongs in a comparison of online clinical services with access to compounded injections. Readers interested in the supplier side can separately examine Hallandale Pharmacy and Empower Pharmacy. Those reviews do not imply that either is the pharmacy for the BoomRX listing discussed here.
Compare Defy’s complete written quote with the Invigor Medical review or our CoreAge Rx review. CoreAge Rx is a featured commercial partner. For Defy, the next useful step is clear product-specific guidance and a complete price, rather than assuming the public store page answers every care question.
Follow the source
References & further reading
- Defy Medical — NAD+ premixed product listing
Checked September 19, 2026. The reviewed listing identifies BoomRX. Its generic instructions contain an unrelated medication reference and require clarification.
- FDA — compounding questions and answers
Compounded drugs are not FDA-approved or reviewed before marketing for safety, effectiveness, or quality.
- FDA — ingredients suitable for sterile compounding
Reports NAD+ injectable adverse events and ingredient-quality concerns.
- Grant et al. (2019) — human NAD+ infusion pilot
Small IV metabolism study; does not establish benefits of home injections.